# Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM

> **NCT00943462** · — · WITHDRAWN · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)**

## Conditions studied

- Astrocytoma, Grade IV
- Giant Cell Glioblastoma
- Glioblastoma Multiforme

## Interventions

- **RADIATION:** External-beam radiation therapy
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT00943462
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible patients could be recruited.
- **Last updated:** 2020-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943462, "Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00943462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*